Alpha-synuclein propagation: New insights from animal models

Movement Disorders : Official Journal of the Movement Disorder Society
Benjamin DehayJeffrey H Kordower

Abstract

Aggregation of alpha-synuclein is implicated in several neurodegenerative diseases collectively termed synucleinopathies. Emerging evidence strongly implicates cell-to-cell transmission of misfolded alpha-synuclein as a common pathogenetic mechanism in synucleinopathies. The impact of alpha-synuclein pathology on neuronal dysfunction and behavioral impairments is being explored in animal models. This review provides an update on how research in animal models supports the concept that misfolded alpha-synuclein spreads from cell to cell and describes how findings in animal models might relate to the disease process in humans. Finally, we discuss the current underlying molecular and cellular mechanisms and future therapeutic strategies targeting alpha-synuclein propagation. © 2015 International Parkinson and Movement Disorder Society.

References

Dec 25, 2002·Neurobiology of Aging·Heiko BraakEva Braak
Sep 23, 2003·Movement Disorders : Official Journal of the Movement Disorder Society·Kurt A Jellinger
Oct 2, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Omar M A El-AgnafDavid Allsop
Nov 1, 2003·Science·A B SingletonK Gwinn-Hardy
Feb 3, 2004·Annals of Neurology·Juan J ZarranzJusto G de Yebenes
Sep 29, 2004·Lancet·Marie-Christine Chartier-HarlinAlain Destée
Jun 25, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·He-Jin LeeSeung-Jae Lee
Mar 16, 2006·Proceedings of the National Academy of Sciences of the United States of America·Ruth A BodnerAleksey G Kazantsev
Oct 5, 2006·Journal of Neural Transmission. Supplementum·K L Double, G M Halliday
Oct 27, 2007·Neuropathology and Applied Neurobiology·C H HawkesH Braak
Feb 23, 2008·The International Journal of Biochemistry & Cell Biology·He-Jin LeeSeung-Jae Lee
Apr 9, 2008·Nature Medicine·Jeffrey H KordowerC Warren Olanow
Sep 5, 2008·Nature Reviews. Neuroscience·Patrik BrundinTamas Revesz
Sep 16, 2008·Molecular and Cellular Neurosciences·Marie WesterlundDagmar Galter
Aug 5, 2009·Proceedings of the National Academy of Sciences of the United States of America·Paula DesplatsSeung-Jae Lee
Jan 15, 2010·The Journal of Biological Chemistry·He-Jin LeeSeung-Jae Lee
May 21, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Evangelia EmmanouilidouKostas Vekrellis
Sep 30, 2010·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Karin M DanzerPamela J McLean
Oct 5, 2010·Progress in Brain Research·Iddo Magen, Marie-Françoise Chesselet
Jan 20, 2011·The Journal of Clinical Investigation·Christian HansenPatrik Brundin
Feb 10, 2011·Neurobiology of Disease·Lydia Alvarez-ErvitiJ Mark Cooper
May 24, 2011·Neurobiology of Disease·Jeffrey H KordowerTimothy J Collier
Aug 5, 2011·Neurobiology of Aging·Anne-Laure MougenotThierry Baron
Aug 28, 2012·Molecular Neurodegeneration·Karin M DanzerPamela J McLean
Oct 31, 2012·Annals of Neurology·Eric C FreundtMichel Brahic
Nov 28, 2012·Nature Reviews. Neurology·Michel GoedertHeiko Braak
Feb 22, 2013·Neurology·Christos ProukakisAnthony H Schapira
Mar 5, 2013·Movement Disorders : Official Journal of the Movement Disorder Society·Silke Appel-CresswellMatthew J Farrer
Mar 8, 2013·Brain : a Journal of Neurology·Masami Masuda-SuzukakeMasato Hasegawa
Mar 26, 2013·Annals of Neurology·Suzanne LesageUNKNOWN French Parkinson's Disease Genetics Study Group
May 25, 2013·EMBO Molecular Medicine·Ayse UlusoyDonato A Di Monte
Nov 13, 2013·Proceedings of the National Academy of Sciences of the United States of America·Joel C WattsStanley B Prusiner
Nov 21, 2013·Acta Neuropathologica Communications·Amanda N SacinoBenoit I Giasson
Jan 3, 2014·Glia·Juan F ReyesElodie Angot

❮ Previous
Next ❯

Citations

Feb 9, 2016·Movement Disorders : Official Journal of the Movement Disorder Society·Nadia StefanovaGregor K Wenning
Mar 2, 2016·Movement Disorders : Official Journal of the Movement Disorder Society·Benjamin DehayErwan Bezard
Dec 1, 2015·Cellular and Molecular Life Sciences : CMLS·Dan LindholmMart Saarma
Apr 1, 2016·Movement Disorders : Official Journal of the Movement Disorder Society·Gianluigi ForloniClaudia Balducci
Apr 22, 2016·Journal of Neural Transmission·Kurt A Jellinger, Gregor K Wenning
May 10, 2016·Revue neurologique·B Dehay, P-O Fernagut
May 20, 2016·BMC Neuroscience·P Githure M'Angale, Brian E Staveley
May 22, 2016·Journal of Neurochemistry·Daniela Maria Vogt WeisenhornWolfgang Wurst
Jul 2, 2016·Molecular Neurodegeneration·Daniel M MasonRehana K Leak
Sep 16, 2016·DNA and Cell Biology·Aaron R Massey, J David Beckham
Mar 18, 2017·Nature Reviews. Neurology·Florian Krismer, Gregor K Wenning
Apr 11, 2017·Movement Disorders : Official Journal of the Movement Disorder Society·Dillon McKenna, John Peever
Oct 7, 2017·Journal of Alzheimer's Disease : JAD·Kurt A Jellinger
Aug 12, 2017·Metabolites·Jesper F HavelundJan Bert Gramsbergen
Oct 13, 2017·Expert Review of Neurotherapeutics·Kurt A Jellinger
Dec 1, 2017·Cell and Tissue Research·Ariadna RecasensBenjamin Dehay
Dec 23, 2017·Translational Neurodegeneration·Daniel Kam Yin ChanGeorge D Mellick
Apr 19, 2017·Assay and Drug Development Technologies·Katarzyna Styczyńska-SoczkaLysimachos Zografos
Feb 27, 2018·Cell and Tissue Research·Jennifer A SteinerPatrik Brundin
Sep 18, 2018·Viral Immunology·Kelsey E Lesteberg, John David Beckham
Jan 18, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Alexei A SurguchevAndrei Surguchov
Nov 8, 2018·Journal of Parkinson's Disease·Kalpana M MerchantUNKNOWN and The Michael J. Fox Foundation Alpha Synuclein Clinical Path Working Group
Feb 10, 2018·Acta Neuropathologica Communications·Ariadna RecasensMiquel Vila
Oct 26, 2018·CPT: Pharmacometrics & Systems Pharmacology·Suruchi BakshiPiet H van der Graaf
Oct 28, 2019·British Journal of Pharmacology·Daniela MercatelliMichele Morari
Jan 12, 2020·Glia·Martina de MajoErik M Ullian
Jun 5, 2020·Quarterly Reviews of Biophysics·Tessa SinnigeMichele Vendruscolo
Feb 23, 2018·Frontiers in Neuroscience·Dasiel O Borroto-EscuelaKjell Fuxe
Jul 22, 2018·Current Medicinal Chemistry·Xin ChenKristopher G Virga
Jun 14, 2019·Acta Neurologica Scandinavica·Xin-Qiao ChenYi-Wen Zhang
Jan 13, 2017·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Zhi-Hua ZhouYong-Zhu Han
Apr 13, 2019·Journal of Neuroinflammation·Alain NdayisabaGregor K Wenning
Dec 14, 2018·Frontiers in Aging Neuroscience·Guoxin ZhangTao Wang
Sep 10, 2017·Movement Disorders : Official Journal of the Movement Disorder Society·J A ObesoA J Stoessl
Jun 26, 2020·Diseases·Neha JoshiShirisha Nagotu
Jul 1, 2020·Frontiers in Cellular Neuroscience·Yuan GuanClaire Xi Zhang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alpha-Synuclein Aggregation

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.

Alpha-Synuclein Aggregation (MDS)

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.

© 2021 Meta ULC. All rights reserved